Pathstone Holdings’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.93M Sell
44,516
-883
-2% -$56.1K 0.01% 826
2025
Q4
$2.88M Buy
45,399
+7,121
+19% +$443K 0.01% 839
2025
Q3
$2.1M Buy
38,278
+13,600
+55% +$560K 0.01% 999
2025
Q2
$815K Sell
24,678
-5,441
-18% -$189K ﹤0.01% 1491
2025
Q1
$1.21M Buy
30,119
+3,825
+15% +$176K 0.01% 1279
2024
Q4
$1.24M Sell
26,294
-8,266
-24% -$429K 0.01% 1249
2024
Q3
$1.82M Buy
34,560
+5,027
+17% +$280K 0.01% 1029
2024
Q2
$1.6M Buy
29,533
+10,615
+56% +$641K 0.01% 1035
2024
Q1
$1.33M Buy
18,918
+7,943
+72% +$614K 0.01% 1113
2023
Q4
$916K Buy
+10,975
New +$397K 0.01% 1129

Other funds holding CYTK